Skip to content

Application of Auriculotherapy on Nursing Professional Stress Levels

Analysis of the Application of Different Forms in Auriculotherapy on Nursing Professional Stress Levels

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01141374
Enrollment
75
Registered
2010-06-10
Start date
2010-01-31
Completion date
2010-06-30
Last updated
2013-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Keywords

Stress

Brief summary

Objectives: Randomized controlled trial aimed to assess stress levels in nursing staff and review the auriculotherapy effectiveness through semi-permanent needles and seeds.

Detailed description

Seventy five participants with average and high scores on the Stress Symptoms List (LSS) were divided in 3 groups (control, needles and seeds). They were evaluated at the baseline, fourth and eighth sessions and 15-day follow-up and received 8 sessions through Shenmen, Kidney and Brainstem points.

Interventions

The chinese auriculotherapy is a intervention used by Chinese Traditional Medicine in order to balance the body energy and to treat several kind of diseases using semi-permanent needles in specific points of the auricular pavilion.

We used the three points Shenmen, Kidney, and Brain Stem with mustard seeds, 1 time per week for 8 sessions.The subjects were instructed to stimulate the points three times a day.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
23 Years to 61 Years
Healthy volunteers
Yes

Inclusion criteria

* Average and high score by the List of Stress Symptoms * Voluntary participation in the study * Availability of time for submission to the sessions

Exclusion criteria

* Pregnancy * Medical license or vacation during the period * Low score of stress

Design outcomes

Primary

MeasureTime frameDescription
Stress Levels After 4 Sessions (2nd Evaluation)after 30 daysScale information: Stress Symptoms List (LSS)with 60 items (better outcome)Low score: 12/29 points; Medium score: 30/60 points; High score: 61/120 points; Very high score (worse outcome): \>120 points.

Secondary

MeasureTime frameDescription
Stress Levels(3rd and 4th Evaluation)after 60 and 75 daysScale Information: Stress Symptoms List (LSS) with 60 items Low score (better outcome): 12/29 points; Medium score: 30/60 points; High score: 61/120 points; Very high score (worse outcome): \>120 points.

Countries

Brazil

Participant flow

Recruitment details

Recruitment was conducted between January and July 2010 at University Hospital. Study participants were professionals from different sectors of the hospital after the invitation and 109 people answered the first questionnaire of stress (LSS). Obeying the exclusion criteria, 75 subjects were enrolled and randomized into three groups.

Pre-assignment details

Withdrawal:employees went on vacation(7),sick leave(2), lost treatment for loss of time, forgetfulness,difficulty of rescheduling (12), withdrawal due to side effects, in this case, nightmares (1); low score (1), not belonging to the nursing staff (3), failure to attend the first session (7) not having completed the questionnaires (1)

Participants by arm

ArmCount
Auriculotherapy by Seeds
Auriculotherapy Group by seeds at Shenmen,kidney and brainstem points,all of them for stress reduction. These points were used 1 time per week for 8 weeks. The subjects were instructed to carry out stimulation 3 times a day for at least 15 times.
26
Auriculotherapy by Needles
Auriculotherapy with semi-permanent needles of 1.8mm, at shenmen, kidney and brainstem points 1 time per week for 8 weeks.
27
Control Group
untreated group
22
Total75

Baseline characteristics

CharacteristicAuriculotherapy by SeedsAuriculotherapy by NeedlesControl GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
26 Participants27 Participants22 Participants75 Participants
Age Continuous45.57 years
STANDARD_DEVIATION 6.4
41.37 years
STANDARD_DEVIATION 8.23
39.25 years
STANDARD_DEVIATION 13.17
42.06 years
STANDARD_DEVIATION 9.27
Region of Enrollment
Brazil
26 participants27 participants22 participants75 participants
score stress63.27 scores on a scale
STANDARD_DEVIATION 26.05
66.82 scores on a scale
STANDARD_DEVIATION 18.56
54.36 scores on a scale
STANDARD_DEVIATION 15.9
61.48 scores on a scale
STANDARD_DEVIATION 20.17
Sex: Female, Male
Female
25 Participants25 Participants21 Participants71 Participants
Sex: Female, Male
Male
1 Participants2 Participants1 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
1 / 263 / 270 / 22
serious
Total, serious adverse events
0 / 260 / 270 / 22

Outcome results

Primary

Stress Levels After 4 Sessions (2nd Evaluation)

Scale information: Stress Symptoms List (LSS)with 60 items (better outcome)Low score: 12/29 points; Medium score: 30/60 points; High score: 61/120 points; Very high score (worse outcome): \>120 points.

Time frame: after 30 days

Population: Of the 109 subjects, four were eliminated for having a low level of stress and 3 for not belonging to nursing staff. Of the 105, 7 didn't appear in the first session. Some lost sessions and were also excluded. One abandoned the treatment because of the side effects, one did not complete the questionnaire, seven went on vacation or sick leave (2).

ArmMeasureValue (MEAN)Dispersion
Control GroupStress Levels After 4 Sessions (2nd Evaluation)49.68 units on a scaleStandard Deviation 17.99
Needle GroupStress Levels After 4 Sessions (2nd Evaluation)54.69 units on a scaleStandard Deviation 27.1
Seeds GroupStress Levels After 4 Sessions (2nd Evaluation)54.00 units on a scaleStandard Deviation 25.04
Comparison: Null hypothesis: there was no statistical difference among 3 groups (control, needles and seeds) after 4 auriculotherapy sessions.p-value: 0.35295% CI: [-76, 23]ANOVA
Secondary

Stress Levels(3rd and 4th Evaluation)

Scale Information: Stress Symptoms List (LSS) with 60 items Low score (better outcome): 12/29 points; Medium score: 30/60 points; High score: 61/120 points; Very high score (worse outcome): \>120 points.

Time frame: after 60 and 75 days

Population: 75 participants were assessed

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupStress Levels(3rd and 4th Evaluation)follow-up72.62 units on a scaleStandard Deviation 31.51
Control GroupStress Levels(3rd and 4th Evaluation)3rd evaluation67.87 units on a scaleStandard Deviation 25.73
Needle GroupStress Levels(3rd and 4th Evaluation)3rd evaluation59.84 units on a scaleStandard Deviation 23.04
Needle GroupStress Levels(3rd and 4th Evaluation)follow-up55.54 units on a scaleStandard Deviation 25.26
Seeds GroupStress Levels(3rd and 4th Evaluation)3rd evaluation67.10 units on a scaleStandard Deviation 23.77
Seeds GroupStress Levels(3rd and 4th Evaluation)follow-up69.20 units on a scaleStandard Deviation 30.03
Comparison: It was carried out the analysis of variance (ANOVA) among the groups in the 3rd assessment (after 60 days and 8 sessions). The main objective was to compare the difference among the control group, seeds and needles and to recognize significant outcomes of auriculotherapy by seeds or needles.p-value: 0.02395% CI: [-67, 37]ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026